Position in RXST
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$61,927
-$345,441 QoQ
Shares Held
12,848
+8.4% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#99
of 151 holders
Holding Since
Sep 2023
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RXST Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Aigen Investment Management, LP holds $10,476,105 across 13 Medical Devices names. RXST ranks #12 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
49,551 | $4,496,257 | |
| 2 | MDT |
Medtronic plc
|
24,962 | $1,952,777 | |
| 3 | EW |
Edwards Lifesciences Corp
|
16,910 | $1,529,678 | |
| 4 | BSX |
Boston Scientific Corp
|
26,161 | $1,116,551 | |
| 5 | PODD |
Insulet Corp
|
3,046 | $463,753 | |
| 6 | HAE |
Haemonetics Corp
|
3,685 | $276,375 | |
| 7 | TMDX |
TransMedics Group, Inc.
|
3,821 | $253,790 | |
| 8 | QTRX |
Quanterix Corp
|
24,328 | $105,096 |
All Filings in RXST
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,927 | 12,848 | Shares | Sole | 2026-08-14 | |
| 2024-12-31 | $407,368 | 11,849 | Shares | Sole | 2025-02-06 | |
| 2024-06-30 | $229,849 | 3,820 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $452,975 | 8,782 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $373,403 | 9,261 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $560,533 | 20,098 | Shares | Sole | 2023-11-13 | |
| No filing history on record for this holder in this stock. | ||||||